Medovate

Medovate is a dynamic medical innovation and development company dedicated to bringing new medical technologies created within the NHS to market in order to improve patient care. Backed by investments from NVM Private Equity and private investors in the United States, Medovate is the first company committed to the development and commercialization of innovative medical technologies. By providing funding at critical moments during development, Medovate will ensure that medical technology innovations identified by the NHS as having high potential are supported through clinical trials and regulatory approval stages, enabling them to become market-ready products as quickly as possible. The company’s remote dermatology or tele-dermatology is a branch of telemedicine (also known as telehealth). Medovate’s TeleDerm service allows you to remotely connect with Dr. Mann or Dr. Springer for virtual dermatology consultations using a HIPAA-compliant video conferencing platform. A remote dermatology consultation only requires a smartphone, tablet, or computer with a built-in camera or webcam, an internet connection, and a link to access the appointment, while our office will facilitate these services.